EE200300400A - Pürimidiiniühendid, nende valmistamismeetod ning kasutamine - Google Patents
Pürimidiiniühendid, nende valmistamismeetod ning kasutamineInfo
- Publication number
- EE200300400A EE200300400A EEP200300400A EEP200300400A EE200300400A EE 200300400 A EE200300400 A EE 200300400A EE P200300400 A EEP200300400 A EE P200300400A EE P200300400 A EEP200300400 A EE P200300400A EE 200300400 A EE200300400 A EE 200300400A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pyrimidine compounds
- pyrimidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100569A SE0100569D0 (sv) | 2001-02-20 | 2001-02-20 | New compounds |
PCT/SE2002/000271 WO2002065979A2 (en) | 2001-02-20 | 2002-02-18 | (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300400A true EE200300400A (et) | 2003-12-15 |
Family
ID=20283059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300400A EE200300400A (et) | 2001-02-20 | 2002-02-18 | Pürimidiiniühendid, nende valmistamismeetod ning kasutamine |
Country Status (23)
Country | Link |
---|---|
US (1) | US7345050B2 (sv) |
EP (1) | EP1373266A2 (sv) |
JP (1) | JP4475869B2 (sv) |
KR (1) | KR20030084935A (sv) |
CN (1) | CN1294131C (sv) |
BG (1) | BG108070A (sv) |
BR (1) | BR0206935A (sv) |
CA (1) | CA2434648A1 (sv) |
CZ (1) | CZ20032235A3 (sv) |
EE (1) | EE200300400A (sv) |
HK (1) | HK1070071A1 (sv) |
HU (1) | HUP0303254A2 (sv) |
IL (1) | IL156781A0 (sv) |
IS (1) | IS6868A (sv) |
MX (1) | MXPA03007320A (sv) |
NO (1) | NO20033679D0 (sv) |
NZ (1) | NZ526783A (sv) |
PL (1) | PL363393A1 (sv) |
RU (1) | RU2003121307A (sv) |
SE (1) | SE0100569D0 (sv) |
SK (1) | SK10252003A3 (sv) |
WO (1) | WO2002065979A2 (sv) |
ZA (1) | ZA200306171B (sv) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
GB0205690D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
JP2005524672A (ja) | 2002-03-09 | 2005-08-18 | アストラゼネカ アクチボラグ | Cdk阻害活性を有するイミダゾリル置換ピリミジン誘導体 |
GB0226583D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Compounds |
GB0311276D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
GB0311274D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
TW200528101A (en) | 2004-02-03 | 2005-09-01 | Astrazeneca Ab | Chemical compounds |
US20080207594A1 (en) | 2005-05-04 | 2008-08-28 | Davelogen Aktiengesellschaft | Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders |
US20080214560A1 (en) * | 2005-10-03 | 2008-09-04 | Astrazeneca Ab | Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease |
UY29827A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | 2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones |
US8648087B2 (en) * | 2005-11-15 | 2014-02-11 | Array Biopharma, Inc. | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
TW200811169A (en) * | 2006-05-26 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
JP2010518014A (ja) * | 2007-01-31 | 2010-05-27 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用な2−アミノピリジン誘導体 |
TWI580694B (zh) | 2007-11-30 | 2017-05-01 | 建南德克公司 | 抗-vegf抗體 |
CN102036953B (zh) * | 2008-03-24 | 2015-05-06 | 诺华股份有限公司 | 基于芳基磺酰胺的基质金属蛋白酶抑制剂 |
AU2009271003A1 (en) | 2008-07-14 | 2010-01-21 | Gilead Sciences, Inc. | Imidazolylpyrimidine compounds as HDAC and/or CDK inhibitors |
EP2303881A2 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
EP2303841A1 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
WO2010014611A1 (en) | 2008-07-28 | 2010-02-04 | Gilead Colorado, Inc. | Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
AU2009308293B2 (en) | 2008-10-22 | 2015-02-05 | Genentech, Inc. | Modulation of axon degeneration |
RU2011140238A (ru) | 2009-04-15 | 2013-05-20 | Астразенека Аб | Имидазол-замещенные пиримидины, полезные в лечении заболеваний, ассоциированных с киназой-3 гликогенсинтазы, таких как болезнь альцгеймера |
ES2463826T3 (es) | 2009-06-08 | 2014-05-29 | Gilead Sciences, Inc. | Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina |
JP5586692B2 (ja) | 2009-06-08 | 2014-09-10 | ギリアード サイエンシーズ, インコーポレイテッド | アルカノイルアミノベンズアミドアニリンhdacインヒビター化合物 |
KR102414221B1 (ko) | 2020-08-04 | 2022-06-27 | 서울시립대학교 산학협력단 | 열전 소자 어셈블리, 이의 제조 방법, 및 이를 포함하는 열전 모듈 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE29032E (en) * | 1969-06-12 | 1976-11-09 | Riker Laboratories, Inc. | 3-Benzoylfluoro-methanesulfonanilides |
FR2179493A1 (en) * | 1972-04-10 | 1973-11-23 | Roussel Uclaf | Amino benzhydrols - choleretics anticonvulsants sedatives and barbiturate potentiators |
DE3042466A1 (de) * | 1980-11-11 | 1982-06-16 | A. Nattermann & Cie GmbH, 5000 Köln | N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
TW225528B (sv) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
-
2001
- 2001-02-20 SE SE0100569A patent/SE0100569D0/sv unknown
-
2002
- 2002-02-18 HU HU0303254A patent/HUP0303254A2/hu unknown
- 2002-02-18 MX MXPA03007320A patent/MXPA03007320A/es unknown
- 2002-02-18 WO PCT/SE2002/000271 patent/WO2002065979A2/en active IP Right Grant
- 2002-02-18 US US10/468,604 patent/US7345050B2/en not_active Expired - Fee Related
- 2002-02-18 EP EP02711620A patent/EP1373266A2/en not_active Withdrawn
- 2002-02-18 CN CNB028052471A patent/CN1294131C/zh not_active Expired - Fee Related
- 2002-02-18 SK SK1025-2003A patent/SK10252003A3/sk unknown
- 2002-02-18 EE EEP200300400A patent/EE200300400A/xx unknown
- 2002-02-18 PL PL02363393A patent/PL363393A1/xx not_active Application Discontinuation
- 2002-02-18 RU RU2003121307/04A patent/RU2003121307A/ru not_active Application Discontinuation
- 2002-02-18 JP JP2002565540A patent/JP4475869B2/ja not_active Expired - Lifetime
- 2002-02-18 CZ CZ20032235A patent/CZ20032235A3/cs unknown
- 2002-02-18 KR KR10-2003-7010874A patent/KR20030084935A/ko not_active Application Discontinuation
- 2002-02-18 IL IL15678102A patent/IL156781A0/xx unknown
- 2002-02-18 BR BR0206935-0A patent/BR0206935A/pt not_active IP Right Cessation
- 2002-02-18 CA CA002434648A patent/CA2434648A1/en not_active Abandoned
- 2002-02-18 NZ NZ526783A patent/NZ526783A/en unknown
-
2003
- 2003-07-08 IS IS6868A patent/IS6868A/is unknown
- 2003-08-07 BG BG108070A patent/BG108070A/bg unknown
- 2003-08-08 ZA ZA200306171A patent/ZA200306171B/xx unknown
- 2003-08-19 NO NO20033679A patent/NO20033679D0/no unknown
-
2005
- 2005-04-06 HK HK05102865A patent/HK1070071A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2002065979A2 (en) | 2002-08-29 |
SE0100569D0 (sv) | 2001-02-20 |
RU2003121307A (ru) | 2005-02-27 |
WO2002065979A3 (en) | 2003-02-20 |
CZ20032235A3 (cs) | 2004-01-14 |
JP2004527486A (ja) | 2004-09-09 |
KR20030084935A (ko) | 2003-11-01 |
MXPA03007320A (es) | 2003-12-04 |
BG108070A (bg) | 2004-07-30 |
IS6868A (is) | 2003-07-08 |
JP4475869B2 (ja) | 2010-06-09 |
IL156781A0 (en) | 2004-02-08 |
PL363393A1 (en) | 2004-11-15 |
NO20033679L (no) | 2003-08-19 |
US20040077642A1 (en) | 2004-04-22 |
HUP0303254A2 (hu) | 2004-01-28 |
ZA200306171B (en) | 2004-11-08 |
US7345050B2 (en) | 2008-03-18 |
BR0206935A (pt) | 2004-06-29 |
CN1294131C (zh) | 2007-01-10 |
NZ526783A (en) | 2005-04-29 |
CN1537112A (zh) | 2004-10-13 |
CA2434648A1 (en) | 2002-08-29 |
EP1373266A2 (en) | 2004-01-02 |
NO20033679D0 (no) | 2003-08-19 |
SK10252003A3 (sk) | 2004-02-03 |
HK1070071A1 (en) | 2005-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05223B1 (et) | Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine | |
EE200300400A (et) | Pürimidiiniühendid, nende valmistamismeetod ning kasutamine | |
EE200200704A (et) | Uued ühendid, meetod nende valmistamiseks ning nende kasutamine | |
EE200200470A (et) | Uued ühendid, meetod nende valmistamiseks ning nende kasutamine | |
IS2940B (is) | Mótefni gegn CD40 | |
DK2206702T3 (da) | Bicyklisk forbindelse, fremstilling og anvendelse deraf | |
DK3808743T3 (da) | HIV-hæmmende pyrimidin-derivater | |
CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
EE200100574A (et) | Uued ühendid, nende valmistamise meetod ning kasutamine | |
IS7287A (is) | Pýrimídín efnasambönd | |
IT1317716B1 (it) | Processo per la preparazione di perfluoropoliossialchileni conterminali ossidrilici. | |
DE60205921D1 (de) | SUBSTITUIERTE 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOç1,2-A!PYRIMIDIN-4-ON- UND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-ç1,2-A!PYRIMIDIN-5(1H)ONDERIVATE | |
MXPA03010020A (es) | PROCEDIMIETO PARA LA PREPARACIoN DE UREA. | |
EE200200697A (et) | Uued ühendid, meetod nende valmistamiseks ning nende kasutamine | |
DK1958938T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid | |
EE200100573A (et) | Uued ühendid, nende valmistamise meetod ning kasutamine | |
EP1191015A4 (en) | AMINO STYRENE R THEN DERIVATIVES, INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND METHOD FOR THE PRODUCTION OF BOTH | |
EE200200410A (et) | Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid | |
MXPA03009210A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS. | |
ITMI20000261A0 (it) | Processo per la preparazione di piridiniliden-ftalidi | |
NO20022643D0 (no) | Reduksjonsprosess | |
FR2797443B1 (fr) | Procede de prepartion de quinoleine-5,8-diones | |
IT1318371B1 (it) | Processo per la preparazione di eterocicli. | |
DK1144382T3 (da) | Fremgangsmåde til fremstilling af 3-substituerede 1,5-diarylpyrazoler | |
ES1048465Y (es) | Pieza de sustentacion y decorativa para somieres. |